Amarin Corp Plc (AMRN)

[rosemountbomber]

Yep. One would think (or at least hope) that even if they prioritize cost savings over patient health care that Vazkepa is a relatively cheap drug -- for the benefit it provides. That article or study posted by Kiwi included drugs that were far more expensive than V.

I am just wondering why HAS recommended excluding Vazkepa from diabetics as I thought R-I had great results within that segment.